South-Eastern Asia vs Spain: Proportion of the target population who received the final dose of
South-Eastern Asia
51.0%
in 2024
Spain
90.0%
in 2024
South-Eastern Asia rank
13th
Spain rank
10th
Proportion of the target population who received the final dose of over time
- South-Eastern Asia
- Spain
How they compare
Spain currently reports 90.0% against 51.0% in South-Eastern Asia, a difference of 39.0%.
That makes Spain's figure about 1.8 times South-Eastern Asia's.
Across all 14 years both countries report, Spain has been ahead every year.
South-Eastern Asia ranks 13th and Spain ranks 10th of 35 groups.
Spain has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | South-Eastern Asia | Spain | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 6.6% | 75.8% | 69.2% | Spain |
| 2020s | 19.2% | 80.4% | 61.2% | Spain |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received the final dose of, South-Eastern Asia or Spain?
- Spain, at 90.0% against 51.0% in South-Eastern Asia as of 2024.
- What is the difference in proportion of the target population who received the final dose of between South-Eastern Asia and Spain?
- 39.0%, with Spain ahead.
- How many years of comparable data are there for South-Eastern Asia and Spain?
- 14 years are reported by both, from 2011 to 2024.
- How do South-Eastern Asia and Spain rank globally for proportion of the target population who received the final dose of?
- South-Eastern Asia ranks 13th and Spain ranks 10th of 35 groups.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received the final dose of human papillomavirus (HPV) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.